POP-OUT | CLOSE

An Information Portal to 105339 Biological Macromolecular Structures

 
TOBRAMYCIN
 
TOY is found in 8 entries
TOY
  •   Chemical Component Summary   Hide
    Name TOBRAMYCIN
    Identifiers (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside
    (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
    Synonyms 4-AMINO-2-[4,6-DIAMINO-3-(3-AMINO-6-AMINOMETHYL-5-HYDROXY
    -TETRAHYDRO-PYRAN-2-YLOXY)-2-HYDROXY-CYCLOHEXYLOXY]-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5
    -DIOL
    Formula C18 H37 N5 O9
    Molecular Weight 467.51 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key NLVFBUXFDBBNBW-PBSUHMDJSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB00684   (Stereoisomeric match)
    Name Tobramycin
    Groups
    • approved
    • investigational
    Description An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the pseudomonas species. It is a 10% component of the antibiotic complex, nebramycin, produced by the same species. [PubChem]
    Synonyms
    • 3'-Deoxykanamycin b
    • Nebramycin 6
    • Nebramycin factir 6
    • Nebramycin-Faktor 6
    • O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine
    • Tobracin (tn)
    • Tobramicina
    • Tobramicina
    • Tobramycin
    • Tobramycine
    • Tobramycinum
    • Tobrex (tn)
    [more]
    Salts Tobramycin Sulfate
    Brand names
    • Aktob
    • Alveoterol
    • Amgy
    • Bactob
    • Belbarmicina
    • BETHKIS
    • Bideon Biotic
    • Bioptic
    • Bramitob
    • Gernebcin
    • Nebcin
    • Obracin
    • Tobi
    • Tobracin
    • Tobramaxin
    • Tobrex
    [more]
    Affected organism Enteric bacteria and other eubacteria
    Indication For the treatment of pseudomonas aeruginosa lung infections. Also being investigated for use in the treatment of sinus infections.
    Pharmacology Tobramycin, an aminoglycoside antibiotic obtained from cultures of <i>Streptomyces tenebrarius</i>, is used in combination with other antibiotics to treat urinary tract infections, gynecologic infections, peritonitis, endocarditis, pneumonia, bacteremia and sepsis, respiratory infections including those associated with cystic fibrosis, osteomyelitis, and diabetic foot and other soft-tissue infections. It acts primarily by disrupting protein synthesis, leading to altered cell membrane permeability, progressive disruption of the cell envelope, and eventual cell death. Tobramycin has in vitro activity against a wide range of gram-negative organisms including <em>Pseudomonas aeruginosa</em>.
    Mechanism of action Tobramycin binds irreversibly to one of two aminoglycoside binding sites on the 30 S ribosomal subunit, inhibiting bacterial protein synthesis. Tobramycin may also destabilize bacterial memebrane by binding to 16 S 16 S r-RNA. An active transport mechanism for aminoglycoside uptake is necessary in the bacteria in order to attain a significant intracellular concentration of tobramycin.
    Route of administration
    • Intravenous
    • Ophthalmic
    • Respiratory (inhalation)
    Categories
    • Anti-Bacterial Agents
    • Aminoglycosides
    ATC-Code
    • J01GB01
    • S01AA12
    AHFS-Code
    • 52:04.04
    • 08:12.02
    CAS number 32986-56-4
    Targets
    Name Sequence search Pharmacological action Actions
    30S ribosomal protein S12   Search  yes inhibitor
     
Ligand Image